411 related articles for article (PubMed ID: 34245901)
1. How to: prophylactic interventions for prevention of Clostridioides difficile infection.
Reigadas E; van Prehn J; Falcone M; Fitzpatrick F; Vehreschild MJGT; Kuijper EJ; Bouza E;
Clin Microbiol Infect; 2021 Dec; 27(12):1777-1783. PubMed ID: 34245901
[TBL] [Abstract][Full Text] [Related]
2. Faecal microbiota transplantation in the treatment of recurrent intestinal Clostridioides difficile infection - a ten-year single-center experience.
Pipek B; Valentová H; Fojtík P; Urban O
Cas Lek Cesk; 2022; 161(3-4):126-130. PubMed ID: 36100450
[TBL] [Abstract][Full Text] [Related]
3. Treatment of
Oksi J; Anttila VJ; Mattila E
Ann Med; 2020; 52(1-2):12-20. PubMed ID: 31801387
[No Abstract] [Full Text] [Related]
4. Prevention of recurrent Clostridioides difficile infection: A systematic review of randomized controlled trials.
Madoff SE; Urquiaga M; Alonso CD; Kelly CP
Anaerobe; 2020 Feb; 61():102098. PubMed ID: 31493500
[TBL] [Abstract][Full Text] [Related]
5. Risk of Clostridium difficile Infection with Systemic Antimicrobial Therapy Following Successful Fecal Microbiota Transplant: Should We Recommend Anti-Clostridium difficile Antibiotic Prophylaxis?
Allegretti JR; Kao D; Phelps E; Roach B; Smith J; Ganapini VC; Kassam Z; Xu H; Fischer M
Dig Dis Sci; 2019 Jun; 64(6):1668-1671. PubMed ID: 30632052
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and Safety of RBX2660 in PUNCH CD3, a Phase III, Randomized, Double-Blind, Placebo-Controlled Trial with a Bayesian Primary Analysis for the Prevention of Recurrent Clostridioides difficile Infection.
Khanna S; Assi M; Lee C; Yoho D; Louie T; Knapple W; Aguilar H; Garcia-Diaz J; Wang GP; Berry SM; Marion J; Su X; Braun T; Bancke L; Feuerstadt P
Drugs; 2022 Oct; 82(15):1527-1538. PubMed ID: 36287379
[TBL] [Abstract][Full Text] [Related]
7. Update of treatment algorithms for Clostridium difficile infection.
Ooijevaar RE; van Beurden YH; Terveer EM; Goorhuis A; Bauer MP; Keller JJ; Mulder CJJ; Kuijper EJ
Clin Microbiol Infect; 2018 May; 24(5):452-462. PubMed ID: 29309934
[TBL] [Abstract][Full Text] [Related]
8. SER-109 (VOWST
Blair HA
Drugs; 2024 Mar; 84(3):329-336. PubMed ID: 38441806
[TBL] [Abstract][Full Text] [Related]
9. Recommendations for the diagnosis and treatment of Clostridioides difficile infection: An official clinical practice guideline of the Spanish Society of Chemotherapy (SEQ), Spanish Society of Internal Medicine (SEMI) and the working group of Postoperative Infection of the Spanish Society of Anesthesia and Reanimation (SEDAR).
Bouza E; Aguado JM; Alcalá L; Almirante B; Alonso-Fernández P; Borges M; Cobo J; Guardiola J; Horcajada JP; Maseda E; Mensa J; Merchante N; Muñoz P; Pérez Sáenz JL; Pujol M; Reigadas E; Salavert M; Barberán J
Rev Esp Quimioter; 2020 Apr; 33(2):151-175. PubMed ID: 32080996
[TBL] [Abstract][Full Text] [Related]
10. Navigating changes in
Durham SH; Le P; Cassano AT
J Manag Care Spec Pharm; 2020 Dec; 26(12-a Suppl):S3-S23. PubMed ID: 33533699
[No Abstract] [Full Text] [Related]
11. Therapeutics for
Khanna S; Voth E
Expert Rev Gastroenterol Hepatol; 2023; 17(9):903-911. PubMed ID: 37606962
[TBL] [Abstract][Full Text] [Related]
12. Fighting against Clostridioides difficile infection: Current medications.
Quan M; Zhang X; Fang Q; Lv X; Wang X; Zong Z
Int J Antimicrob Agents; 2024 Jul; 64(1):107198. PubMed ID: 38734214
[TBL] [Abstract][Full Text] [Related]
13. Fecal microbiota transplantation (FMT) for C. difficile infection, just say 'No'.
Tan X; Johnson S
Anaerobe; 2019 Dec; 60():102092. PubMed ID: 31472233
[TBL] [Abstract][Full Text] [Related]
14. Microbiota restoration for recurrent Clostridioides difficile: Getting one step closer every day!
Khanna S
J Intern Med; 2021 Aug; 290(2):294-309. PubMed ID: 33856727
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of Fecal Microbiota Transplantation for First Recurrent Clostridioides difficile Infection.
Aby ES; Vaughn BP; Enns EA; Rajasingham R
Clin Infect Dis; 2022 Oct; 75(9):1602-1609. PubMed ID: 35275989
[TBL] [Abstract][Full Text] [Related]
16. European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults.
van Prehn J; Reigadas E; Vogelzang EH; Bouza E; Hristea A; Guery B; Krutova M; Norén T; Allerberger F; Coia JE; Goorhuis A; van Rossen TM; Ooijevaar RE; Burns K; Scharvik Olesen BR; Tschudin-Sutter S; Wilcox MH; Vehreschild MJGT; Fitzpatrick F; Kuijper EJ;
Clin Microbiol Infect; 2021 Dec; 27 Suppl 2():S1-S21. PubMed ID: 34678515
[TBL] [Abstract][Full Text] [Related]
17. Long-term durability and safety of fecal microbiota transplantation for recurrent or refractory Clostridioides difficile infection with or without antibiotic exposure.
Lee CH; Chai J; Hammond K; Jeon SR; Patel Y; Goldeh C; Kim P
Eur J Clin Microbiol Infect Dis; 2019 Sep; 38(9):1731-1735. PubMed ID: 31165961
[TBL] [Abstract][Full Text] [Related]
18. Systematic Review with Meta-Analysis: Fecal Microbiota Transplantation for Severe or Fulminant Clostridioides difficile.
Tixier EN; Verheyen E; Luo Y; Grinspan LT; Du CH; Ungaro RC; Walsh S; Grinspan AM
Dig Dis Sci; 2022 Mar; 67(3):978-988. PubMed ID: 33748913
[TBL] [Abstract][Full Text] [Related]
19. Durability of Response to Fecal Microbiota Transplantation After Exposure to Risk Factors for Recurrence in Patients With Clostridioides difficile Infection.
Saha S; Mara K; Pardi DS; Khanna S
Clin Infect Dis; 2021 Oct; 73(7):e1706-e1712. PubMed ID: 32976567
[TBL] [Abstract][Full Text] [Related]
20. Predictors of Fecal Microbiota Transplant Failure in Clostridioides difficile Infection : An Updated Meta-analysis.
Beran A; Sharma S; Ghazaleh S; Lee-Smith W; Aziz M; Kamal F; Acharya A; Adler DG
J Clin Gastroenterol; 2023 Apr; 57(4):389-399. PubMed ID: 35050941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
